Bioanalysis Zone

Evolution of fit-for-purpose biomarker validations: an LBA perspective


Biomarker ligand-binding assays need to be validated for use on clinical studies in the drug development process. There is not one single guidance to cover all types of biomarker assays and their intended uses. Therefore,

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.



Leave A Comment